NEWS

   

    home.aspx
  • Novartis Demands Outside Counsel Make Tough Diversity Guarantees

    Novartis AG is demanding that its 22 “preferred” Big Law firms make specific diverse staffing commitments for each engagement with the pharma giant or face punishment in the form of reduce...


    READ MORE
    https://news.bloomberglaw.com/business-and-practice/novartis-demands-outside-counsel-make-tough-diversity-guarantees?usertype=External&bwid=00000170-33658
  • Patient successfully treated for coronavirus in the US

    The Ebola drug Remdesivir, made by Gilead Sciences, was given to an American who is 35 years old. The doctors reported that on 26 January his condition seemed to improve within a day, and by 30 Januar...


    READ MORE
    http://www.pharmafile.com/news/541290/patient-successfully-treated-coronavirus-us3655
  • Durham’s Mycovia Pharma extends clinical trial of anti-fungal drug for yeast infections

    Mycovia Pharmaceuticals, a developer of drugs in women’s health, has initiated “extension studies” as part of its ongoing Phase 3 global clinical trial of its lead drug candidate for...


    READ MORE
    https://www.wraltechwire.com/2020/02/11/durhams-mycovia-pharma-extends-clinical-trial-of-anti-fungal-drug-for-yeast-infections/3656
  • Coronavirus draws attention to FDA oversight of Chinese drugs

    Lawmakers are raising concerns anew about the U.S. reliance on foreign drug manufacturing amid the Wuhan coronavirus outbreak that has pushed FDA inspectors out of China. The novel disease outbreak co...


    READ MORE
    https://www.politico.com/newsletters/prescription-pulse/2020/02/07/coronavirus-draws-attention-to-fda-oversight-of-chinese-drugs-4882693652
  • Coronavirus: The Latest Problem Big Pharma Won’t Solve

    Time for new pharmaceutical-innovation models. The pharmaceutical industry is one of the most profitable on earth, expected to be worth $1.4 trillion by the end of 2020. Last year, the four drug compa...


    READ MORE
    https://www.barrons.com/articles/coronavirus-the-latest-problem-big-pharma-wont-solve-515810786003653
  • Small Molecules Lead in Recent New Drug Approvals

    Small molecules still lead over biologics in recent drug approvals, accounting for nearly three-fourths of drug approvals over the past several years, but will small molecules' dominance continue?...


    READ MORE
    https://dcatvci.org/6326-small-molecules-lead-in-recent-new-drug-approvals3649
  • Gilead joins GSK, J&J in offering coronavirus vaccine options

    With the death toll in China topping 425, the coronavirus, now officially classified as a global health threat by the World Health Organisation (WHO), is showing no signs of slowing down. More than 20...


    READ MORE
    http://www.pharmatimes.com/news/gilead_joins_gsk,_jj_in_offering_coronavirus_vaccine_options_13242793650
  • Angelini Pharma, Inc. U.S. Launches First Infection Prevention Portfolio

    Angelini Pharma Inc. U.S., an international healthcare company headquartered in Maryland, is tackling the epidemic of healthcare-acquired infections (HAIs) with their new line of infection prevention ...


    READ MORE
    https://www.prnewswire.com/news-releases/angelini-pharma-inc-us-launches-first-infection-prevention-portfolio-300997077.html3647
  • Insurers Take Aim at Big Pharma. This Small-Cap Stock Stands to Win.

    The premise of generic drugs was simple enough. Branded medicines protected by a patent tend to be overpriced, but the equivalent therapy made by other companies once a patent expires should lead to p...


    READ MORE
    https://www.fool.com/investing/2020/01/30/insurers-take-aim-at-big-pharma-this-small-cap-sto.aspx3644

EVENTS

Conferences

PBMI 25th National Conference

PBMI 25TH NATIONAL CONFERENCE

March 02-04, 2020
Next year, PBMI will celebrate our 25th National Conference Anniversary in Orlando, Florida at the Rosen Shingle Creek Hotel, March 2-4, 2020.  For more than two decades, we’ve hosted this meeting to educate and help healthcare stakeholders stay up to date on best practices/strategies for...

3rd International Conference and Exhibition on
Pharmaceutics & Advanced Drug Delivery Systems

3RD INTERNATIONAL CONFERENCE AND EXHIBITION ON PHARMACEUTICS & ADVANCED DRUG DELIVERY SYSTEMS

March 04-05, 2020
The Global Pharmaceutical Sector is rapidly transforming with innovative therapeutic approaches and technological breakthroughs. In this fast-growing sector, Pharmaceutical Sciences 2020 thrives to gather like-minded people from various disciplines ofPharmaceutical and Healthcare Sectors in a single...

3rd GLOBAL PHARMA SUMMIT

3RD GLOBAL PHARMA SUMMIT

March 16-17, 2020
This scientific occasion will be a gathering of Pharmacists, pharmacologists, Healthcare Professionals, Academicians, Researchers, Scientists, Industrialists and Students from across the Globe and aims to provide a hostilic exposure on cutting-edge technologies, new therapeutics, research and develo...

Clinical Microbiology and Immunology

CLINICAL MICROBIOLOGY AND IMMUNOLOGY

March 16-17, 2020
Clinical Microbiology 2020 brings the world’s leading Microbiologists, Immunologists,  academic scientists, researchers and research scholars, Microbiology and Immunology professionals concerned with the profession and practice of Microbiology and Immunology to exchange their experiences,...

The 8th Annual Global Pharmaceutical and Medical Meetings Summit

THE 8TH ANNUAL GLOBAL PHARMACEUTICAL AND MEDICAL MEETINGS SUMMIT

February 10-12, 2020
The 8th Annual Global Pharmaceutical and Medical Meetings Summit

4th Annual Microbiome Movement, Drug Development, Europe

4TH ANNUAL MICROBIOME MOVEMENT, DRUG DEVELOPMENT, EUROPE

February 04-05, 2020
As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effecti...

The Digital Pharma Advances

THE DIGITAL PHARMA ADVANCES

January 29-29, 2020
Powerfully Target & Engage HCPs & Patients & Deliver Real-World Results With Integrated, Innovative Digital Strategies.Customer-Centric, Value-Adding, Multi-Channel Digital Pharma Marketing Strategies.

International Conference on Metabolic Diseases and Liver Cancer

INTERNATIONAL CONFERENCE ON METABOLIC DISEASES AND LIVER CANCER

December 16-17, 2019
“INTERNATIONAL CONFERENCE ON METABOLIC DISEASES AND LIVER CANCER ’’ is organized in order to bring light and anticipate to the dark sides of human liver cancer and irregular human metabolic diseases which are prevailing worldwide. This conference is effective on all sides as it giv...

 

Webinars

FEB 18, 2020 | 01:00PM
APPLICATIONS OF IMMUNOSEQUENCING IN AUTOIMMUNITY
Immunosequencing, the science of profiling T- and B-cell receptors, enables incredible insight into the immune system and its role in numerous disease states. This webinar will give a brief overview of Adaptive Biotechnologies’ immunoSEQ® Assay and delve into how immunosequencing...
FEB 20, 2020 | 03:00am
INDUSTRY TRENDS IN PRE-APPROVAL ACCESS TO MEDICINES
Expanded access to medicines (pre-approval access, early access, compassionate use, named patient supply) is becoming more and more a part of the standard development and launch process of bringing a pharmaceutical product to market. The focus of pipelines on rare diseases and oncology, co...
FEB 25, 2020
2020 ANNUAL PHARMACEUTICAL CLEANING VALIDATION TRAINING PROGRAM
Pharmaceutical manufacturers must validate their cleaning processes to ensure compliance with the latest regulatory requirements. Effective and consistent cleaning procedures must be in place and thoroughly validated to avoid cross-contamination in manufacturing and cleaning equipment. In ...
FEB 25, 2020
2020 PHARMACEUTICAL CLEANING VALIDATION REGULATORY COMPLIANCE TRAINING PROGRAM
This intensive 8-part live training program on the topic of Cleaning Validation will consist of 8 live training sessions of 2 hours each. It will include over 20 hours of live presentation and live Q&A delivered twice a month over the course of 4 months.
FEB 27, 2020 | 12:00pm
ACCELERATING APPROVAL FOR CELL AND GENE THERAPIES
After decades of slow and steady progress, cell and gene therapies are experiencing important breakthroughs, demonstrating potential to slow disease progression, improve outcomes, and in some cases, potentially cure an array of illnesses. However, navigating complex clinical and regulatory...
FEB 27, 2020 | 11:00am
WE CHAT IN CHINA.HOW PHARMA AND MARKET RESEARCHES CAN UTILISE THIS EMERGING DIGITAL PLATFORM
Join us for this live webinar in which Emerging Market experts, Rachel Howard and Parisa Valadan, will discuss the features and opportunities of WeChat. They will address the impact of doing business in China, share examples of how WeChat is being used in healthcare, and discuss what this ...

HOW PHARMA MARKETING CAN STAY AHEAD OF THE EVOLVING CUSTOMER JOURNEY
New developments in data and digital are changing traditional customer journeys and forcing pharmaceutical companies to evolve in order to keep up.
ENSURING COMPLIANCE FOR PHARMA COMPANIES THROUGH LOCAL LABEL DEVIATIONS
Many global pharmaceutical companies are often faced with a volume of content in the field that has grown to a point where the quality of that labeling is unknown. Assessment of what exists and correcting the process to avoid pitfalls in the future can be a daunting task.
DISCOVER THE MEGATRENDS REMAPPING THE PHARMACEUTICAL MARKET
New Manatt Health Webinar Reveals the Megatrends Reinventing the Ways Your Patient, Provider and Payer Customers Think—and How You Should Respond to Succeed.
MEMBRANE-BASED WATER FOR INJECTION
Historically, distillation has been the most common technology used to produce Water for Injection (WFI), due to prior process advantages and historical regulatory requirements.  Changes in the European Pharmacopeiano longer require the use of distillation systems to produce WFI. In t...
USE OF CANNABIS IN MEDICINE - DRUG OR DRUG?
In the webinar, Prof. Kirsten Müller-Vahl gives an overview of the use of cannabis in medicine, explains the basics of the endocannabinoid system and introduces the various cannabis compounds - from different cannabis flowers to cannabis-based drugs based on extracts and synthetic can...
WHAT PHARMACEUTICAL MARKETERS CAN DO NOW TO STAY AHEAD OF THE EVOLVING CUSTOMER JOURNEY
In association with pharmaphorum, Tag discusses what pharmaceutical marketers can to do stay ahead of the evolving customer journey.

RESOURCES

What are drugs? What do they do? How do they do what they do? These questions are part of the field of pharmacology, and over this series we will learn all about a wide variety of different drugs that...

Pain management is one of the most common reasons for the use of medical cannabis products. However, despite many jurisdictions – including Canada, Germany, and the Netherlands – now allow...

The drugstore chain agreed to pay $7.5 million in fines after an unlicensed pharmacist at several San Francisco Bay locations illegally filled more than 700,000 prescriptions over a ten-year period. A...

There aren't too many people in healthcare who can say they've worked for both a Big Pharma company AND a hot health tech startup, so we're lucky we had a chance to talk with Kristin Millb...

The pharmaceutical industry's top earners are cancer drugs  a sentence that will be read to the surprise of no one. When sussing out why oncological therapies cost so much, the usual suspect ...

Scientists from Trinity College Dublin have discovered that two very different species of bacteria have evolved distinct, powerful antibiotic arsenals for use in the war against their bacterial neighb...

A type of immunotherapy in which T cells are given to a patient to help the body fight diseases. In cancer therapy, T cells are usually taken from the patient’s own blood or tumor tissue, grown ...

Despite halting development after disappointing trial findings in March, Biogen now plans to submit Alzheimer’s candidate aducanumab for FDA approval, after new analysis showed the drug just mig...

If a pharma company succeeded in developing a vaccine for the coronavirus in the timeframe many have promised, it would be a historic milestone for the industry. Since cases of the novel coronavirus i...